TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo.
Lynch K, Treacy O, Chen X, Murphy N, Lohan P, Islam MN, Donohoe E, Griffin MD, Watson L, McLoughlin S, O'Malley G, Ryan AE, Ritter T.
Lynch K, et al. Among authors: lohan p.
Mol Ther. 2020 Sep 2;28(9):2023-2043. doi: 10.1016/j.ymthe.2020.05.023. Epub 2020 May 30.
Mol Ther. 2020.
PMID: 32531237
Free PMC article.